PTC CLINIC
Informace pro odborníky

Literatura:

1 . Gomez DR, Li H, Chang JY. Proton Therapy for early-stage non-small cell lung cancer: Review article. . Transl Lung Cancer Res 2018;7(2):199-204 . 2018.

2 . Andrea Bezjak, Rebecca Paulus, Laurie E. Gaspar, Robert D. Timmerman, William L. Straube, William F. Ryan, Yolanda I. Garces, Anthony T. Pu, Anurag K. Singh, Gregory M. Videtic, Ronald C. McGarry, Puneeth Iyengar, Jason R. Pantarotto, James J. Urbanic,. Safety and Efficacy of a Five-Fraction Stereotactic Body Radiotherapy Schedule for Centrally Located Non–Small-Cell Lung Cancer: NRG Oncology/RTOG 0813 Trial ,. Journal of Clinical Oncology 2019 37:15, 1316-1325 . 2019.

3. Chang JY, Komaki R, Wen HY et al. Toxicity and patterns of failure of adaptive/ablative proton therapy for early-stage, medically inoperable non-small cell lung cancer. . Int J Radiat Oncol Biol Phys. 2011 Aug 1;80(5):1350-7. Epub 2011 Jan 20. 2011.

4. Register SP, Zhang X, Mohan R, Chang JY. Proton stereotactic body radiation therapy for clinically challenging cases of centrally and superiorly located stage I non-small-cell lung cancer. . Int J Radiat Oncol Biol Phys. 2011 Jul 15;80(4):1015-22. Epub 20. 2011.

5. Chang JY, Komaki R, Lu C, Wen HY, Allen PK, Tsao A, Gillin M, Mohan R, Cox JD. Phase 2 study of high-dose proton therapy with concurrent chemotherapy for unresectable stage III nonsmall cell lung cancer. . Cancer. 2011 Mar 22. doi: 10.1002/cncr.26080. 2011.

6. Chang JY, Komaki R, Lu C, Wen HY, Allen PK, Tsao A, Gillin M, Mohan R, Cox JD. Phase 2 study of high-dose proton therapy with concurrent chemotherapy for unresectable stage III nonsmall cell lung cancer. . Cancer. 2011 Mar 22. doi: 10.1002/cncr.26080. 2011.

7. Zhang X. et al. Intensity-modulated proton therapy reduces the dose to normal tissue compared with intensity-modulated radiation therapy or passive scattering proton therapy and enables individualized radical radiotherapy for extensive stage IIIB non-smal. -cell lung cancer: a virtual clinical studyInt. J. Radiation Oncology Biol. Phys., Vol. 77, No. 2, pp. 357–366, 2010. 2010, stránky pp. 357–366.

8. al., Koay EJ et. Adaptive/Nonadaptive Proton Radiation Planning and Outcomes in a Phase II Trial for Locally Advanced Non-small Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 2012 Apr 27. 2012.

9. Gjyshi O, Liao Z., MD. Proton Therapy for locally advanced non-small cell lung cancer: Review Article. Br J Radiol 2019;92:20190378.

10. Abigail T.Berman, Sara St.James and Ramesh Rengan et al. Proton Beam Therapy for Non-Small Cell lung Cancer: Curent Clinical Evidence and Future Directions. Cancers 2015,7,1178-1190. 2015.

11. Melissa A.L. Vyfhuis, Nasarachi Onyeuku, Tejan Diwanji, Sina Mossahebi, Neha P. Amin, Shahed N. Badiyan, Pranshu Mohindra, Charles B. Simone,. Advances in proton therapy in lung cancer. Ther Adv Respir Dis. 2018 Jan-Dec; 12:. Vol. 12: 1–16, DOI: 10.1177/1753466618783878, 2018.

 12. Herskovic A, Mauer E, Christos P, et al. Role of Postoperative Radiotherapy in Pathologic Stage IIIA (N2) Non-Small Cell Lung Cancer in a Prospective Nationwide Oncology Outcomes Database. J Thorac Oncol 2017;12:302-13. [Crossref] [PubMed]. 2017.

13. Lally BE, Zelterman D, Colasanto JM, et al. Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database. J Clin Oncol 2006;24:2998-3006. [Crossref] [PubMed]. 2006.

14. Douillard JY, Rosell R, De Lena M, et al. Impact of postoperative radiation therapy on survival in patients with complete resection and stage I, II, or IIIA non-small-cell lung cancer treated with adjuvant chemotherapy:. Int J Radiat Oncol Biol Phys 2008;72:695-701. [Crossref] [PubMed] . 2008, str. the adjuvant Navelbine International Trialist Association (ANITA) Randomized Trial. .

15. Billiet C, Peeters S, Decaluwe H, et al. Outcome after PORT in ypN2 or R1/R2 versus no PORT in ypN0 Stage III-N2 NSCLC after Induction Chemotherapy and Resection. J Thorac Oncol 2016;11:1940-53. [Crossref] [PubMed].

16. Robinson CG, Patel AP, Bradley JD, et al. Postoperative radiotherapy for pathologic N2 non-small-cell lung cancer treated with adjuvant chemotherapy: a review of the National Cancer Data Base. J Clin Oncol 2015;33:870-6. [Crossref] [PubMed. 2015.

17. Billiet C, Decaluwe H, Peeters S, et al. Modern post-operative radiotherapy for stage III non-small cell lung cancer may improve local control and survival: a meta-analysis. Radiother Oncol 2014;110:3-8. 2014.

18. al., Shepherd AF et. Proton Therapy for post-operative radiation therapy of non-small cell lung cancer. Transl Lung Cancer Res 2018;7 (2) : 205-209. 2018.

19. Berman AT, Teo BKK, Dolney D ,et al. An in-silico comparison of proton beam and IMRT for postoperative radiotherapy in completely rescted stage IIIA non-small cell lung cancer. Radiat.Oncol.2013,8, 144 (CrossRef) (PubMed). 2013.

20. Terada Y, Isaka M, Harada H, et al. Radiotherapy for local recurrence of non-small-cell lung cancer after lobectomy and lymph node dissection-can local recurrence be radically cured by radiation?. . Jpn J Clin Oncol. 2020;50(4):425‐433. doi:10.1093/jjco/hyz188.

21. Shahed N. Badiyan, MD,Michael S. Rutenberg, MD, PhD,Bradford S. Hoppe, MD,Carlos Vargas, MD Steven J. Feigenberg, MD,Charles B. Simone II, MD .et all. Clinical Outcomes of Patients With Recurrent Lung Cancer Reirradiated With Proton Therapy on the Proton Collaborative Group and University of Florida Proton Therapy Institute Prospective Registry Studies, ORIGINAL REPORT|,. |, Practical radiation Oncology , VOLUME 9, ISSUE 4, P280-288, JULY 01, 2019. 2019.

22. McAvoy S, Ciura K, Wei C, et al. Definitive reirradiation for locoregionally recurrent non-small cell lung cancer with proton beam therapy or intensity modulated radiation therapy: predictors of high-grade toxicity and survival outcomes. Int J Radiat Oncol Biol Phys 2014;90:819-27. [Crossref] [PubMed]. 2014.

23. Chao HH, Berman AT, Simone CB 2nd, et al. Multi-institutional prospective study of reirradiation with proton beam radiotherapy for locoregionally recurrent non-small cell lung cancer  J Thorac Oncol 2016: 12: 128-137. 2016.

24. Vyfhuis MAL, Rice S, Remick J et al. Reirradiation for locoregionally recurrent non-small cell lung cancer: Review Article. J Thorac Dis 2018;10(Suppl 21): S2522-S2536. 10 2018, stránky S2522-S2536.

25. Kim, H., Pyo, H., Noh, J.M. et al. Preliminary result of definitive radiotherapy in patients with non-small cell lung cancer who have underlying idiopathic pulmonary fibrosis: comparison between X-ray and proton therapy. Radiat Oncol 14, 19 (2019) . https://doi.org/10.1186/s13014-019-1221-4, 2019.

26. Alexander Fabian, David Krug. Oligometastasierung unterschiedlicher Entitäten – Stereotaktische ablative Radiotherapie vs. Palliativversorgung: Ergebnisse einer weiteren randomisierten Phase II Studie „SABR-COMET“(Palma et al., Lancet 2019). (Palma et al., Lancet 2019) Christian-Albrechts-Universität zu Kiel Klinik für Strahlentherapie am UKSH Kiel. 2019.

27. Alexandra Haas, časopis Onkologie, Dávková eskalace v léčbě NSCLC protonovou radioterapií – https://www.ptc.clinic/davkova-eskalace-v-lecbe-nsclc-protonovou-radioterapii/

28. Chang JY, Jabbour SK, De Ruysscher D, Schild SE, Simone CB 2nd, Rengan R, Feigenberg S, Khan AJ, Choi NC, Bradley JD, Zhu XR, Lomax AJ, Hoppe BS; International Particle Therapy Co-operative Group (PTCOG) Thoracic Subcommittee. Consensus Statement on Proton Therapy in Early-Stage and Locally Advanced Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 2016 May 1;95(1):505-516. doi: 10.1016/j.ijrobp.2016.01.036. Epub 2016 Jan 23. PMID: 27084663.

29. Mesko S, Gomez D. Proton Therapy in Non-small Cell Lung Cancer. Curr Treat Options Oncol. 2018 Nov 27;19(12):76. doi: 10.1007/s11864-018-0588-z. PMID: 30483900.

30. Nakamura M, Ishikawa H, Ohnishi K, Mori Y, Baba K, Nakazawa K, Shiozawa T, Sekine I, Maruo K, Okumura T, Sakurai H. Effects of lymphopenia on survival in proton therapy with chemotherapy for non-small cell lung cancer. J Radiat Res. 2023 Mar 23;64(2):438-447. doi: 10.1093/jrr/rrac084. PMID: 36592478; PMCID: PMC10036091.